跳到正文
原文
Endpoints News· @endpts · X·· 5 天前AI 评分47
AI 导读

Neurosterix 为其精神分裂症药物融资 1.05 亿美元,并引入参与开发 Cobenfy 的 Karuna 团队。报道链接为 https://endpoints.news/neurosterix-pulls-in-105m-for-schizophrenia-drug-recruits-cobenfy-vets/。

正文

Neurosterix raised $105M for its schizophrenia drug and brought on the Karuna team behind Cobenfy. https://endpoints.news/neurosterix-pulls-in-105m-for-schizophrenia-drug-recruits-cobenfy-vets/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial

来源:Endpoints News · x.com